See more : Seach Medical Group Ltd (SEMG.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Cannagistics, Inc. (CNGT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannagistics, Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Ways Technical Corp., Ltd. (3508.TWO) Income Statement Analysis – Financial Results
- Videndum Plc (VTEPF) Income Statement Analysis – Financial Results
- Victoria’s Secret & Co. (VSCO) Income Statement Analysis – Financial Results
- AltPlus Inc. (3672.T) Income Statement Analysis – Financial Results
- Mo-BRUK S.A. (MBRFF) Income Statement Analysis – Financial Results
Cannagistics, Inc. (CNGT)
About Cannagistics, Inc.
Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 2.33M | 2.22M | 826.37K | 7.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 16.02K | 29.77K | 2.15M | 2.04M | 792.17K | 10.78M | 0.00 | 0.00 | 0.00 | 0.00 | 25.14K | 5.00K | 7.00K | 7.00K |
| Gross Profit | 0.00 | 0.00 | -16.02K | -29.77K | 179.50K | 180.48K | 34.20K | -10.78M | 0.00 | 0.00 | 0.00 | 0.00 | -25.14K | -5.00K | -7.00K | -7.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 7.70% | 8.13% | 4.14% | -143,669.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 559.89K | 1.54M | 1.24M | 866.48K | 449.42K | 51.76M | 642.26K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -574.09K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 559.89K | 1.54M | 1.24M | 866.48K | 449.42K | 51.76M | 642.26K | 68.18K | 5.78K | 0.00 | 183.94K | 144.56K | 24.93K | 14.31K |
| Other Expenses | 0.00 | 0.00 | 277.66K | 1.25M | 0.00 | 0.00 | 100.00K | 38.39M | 486.25K | 0.00 | 0.00 | -320.00K | 0.00 | 0.00 | 198.00 | 198.00 |
| Operating Expenses | 0.00 | 0.00 | 559.89K | 1.54M | 1.24M | 866.48K | 449.42K | 51.76M | 642.26K | 68.18K | 5.78K | -320.00K | 183.94K | 144.56K | 24.93K | 14.51K |
| Cost & Expenses | 0.00 | 0.00 | 559.89K | 1.54M | 3.39M | 2.91M | 1.24M | 62.54M | 642.26K | 68.18K | 5.78K | -320.00K | 209.08K | 149.56K | 24.93K | 21.51K |
| Interest Income | 0.00 | 0.00 | 87.04K | 87.04K | 88.47K | 45.89K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 760.58K | 464.81K | 253.21K | 74.67K | 35.21K | 4.24M | 18.93K | 4.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 646.93K | 8.81K | 8.81K | 15.80K | 21.22K | 4.00M | -16.20K | 0.00 | 0.00 | 0.00 | -187.28K | -47.61K | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | -1.69M | -6.40M | -1.72M | -13.17M | -62.53M | -642.26K | -68.18K | -5.78K | 320.00K | -396.35K | -197.16K | -24.93K | -21.51K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -41.26% | -28.11% | -50.25% | -833,748.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | -646.93K | -1.70M | -1.06M | -686.00K | -415.22K | -62.53M | -642.26K | -68.18K | -5.78K | 320.00K | -209.08K | -149.56K | -24.93K | -21.51K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -45.44% | -30.89% | -50.25% | -833,748.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -16.70M | -556.23K | -1.56M | -1.13M | -12.79M | -2.40M | -18.93K | -21.18K | 0.00 | 0.00 | -187.28K | -47.61K | 3.42K | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -2.39M | -2.25M | -3.68M | -1.81M | -13.21M | -65.92M | -661.20K | -89.36K | -5.78K | 320.00K | 0.00 | 0.00 | -21.51K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -157.77% | -81.57% | -1,598.35% | -878,868.93% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 586.50K | 649.15K | 253.21K | -20.93K | -854.14K | 4.22M | 16.20K | -4.98K | 0.00 | 0.00 | 187.28K | 47.61K | 21.51K | 21.51K |
| Net Income | 0.00 | 0.00 | -2.98M | -2.90M | -3.93M | -1.81M | -13.19M | -65.92M | -661.20K | -89.36K | -5.78K | 320.00K | -396.35K | -197.16K | -25.04K | -21.51K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -168.64% | -81.57% | -1,595.82% | -878,868.93% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.02 | -0.03 | -0.15 | -0.13 | -1.05 | -39.10 | -0.79 | -0.21 | -0.15 | 16.00 | -23.13 | -11.51 | -1.51 | -7.81 |
| EPS Diluted | 0.00 | 0.00 | -0.02 | -0.03 | -0.15 | -0.13 | -1.05 | -39.10 | -0.79 | -0.21 | -0.15 | 16.00 | -23.13 | -11.51 | -1.51 | -7.81 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 151.20M | 98.21M | 26.01M | 14.36M | 12.57M | 1.69M | 841.82K | 417.16K | 38.23K | 20.00K | 17.14K | 17.14K | 16.56K | 2.76K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 151.20M | 98.21M | 26.01M | 14.36M | 12.57M | 1.69M | 841.82K | 417.16K | 38.23K | 20.00K | 17.14K | 17.14K | 16.56K | 2.76K |
Source: https://incomestatements.info
Category: Stock Reports